scholarly journals Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Jean Lucas Kremer ◽  
Thais Barabba Auricino ◽  
Bárbara dos Santos Passaia ◽  
Claudimara Ferini Pacicco Lotfi
Keyword(s):  
Epithelial Mesenchymal Transition ◽  
Methylation Status ◽  
Carcinoma Cells ◽  
Migration And Invasion ◽  
Steroidogenic Factor 1 ◽  
Mesenchymal Transition ◽  
Aggressive Cancer ◽  
Potential Strategy ◽  
Plasmid Transfection ◽  
Adrenocortical Carcinomas

Abstract Background Adrenocortical carcinomas (ACC) are rare and aggressive cancer. Our previous study has revealed that the transcription factor 21, TCF21, is downregulated in ACC and regulates steroidogenic factor 1 (SF-1) binding to the SF-1 E-box promoter. In addition, it could be found that TCF21 is a predictor of overall survival (OS) in adult carcinomas. Methods In this study, it was investigated the correlation between TCF21 expression and the promoter methylation status in adrenocortical tumor cells, carcinomas and adenoma. The biological function and potential molecular mechanism of TCF21 restoration in migration and invasion of ACC cells was examined. Results We could be demonstrated a negative correlation between the level of TCF21 expression and methylation of its promoter in adenoma and carcinoma cells indicating the epigenetic control of TCF21 expression. It was also demonstrated that the expression of TCF21 inhibits migration and invasion in the ACC cell line, H295R cells, using plasmid transfection to express TCF21. Furthermore, it could be investigated the TCF21 function as tumor suppressor probably through Kisspeptin 1 (KISS-1) expression and epithelial–mesenchymal transition (EMT) reversion, as well as the modulation of several metalloproteinases in ACC cells. Conclusions Our results suggest that enhancement of TCF21 expression levels may be a potential strategy to revert invasive abilities in adrenocortical carcinomas.

scholarly journals Upregulation of TCF21 Inhibits Migration of Adrenocortical Carcinoma Cells

2021 ◽  
Author(s):  
Jean Lucas Kremer ◽  
Thais Barabba Auricino ◽  
Bárbara dos Santos Passaia ◽  
Claudimara Ferini Pacicco Lotfi
Keyword(s):  
Epithelial Mesenchymal Transition ◽  
Methylation Status ◽  
Carcinoma Cells ◽  
Migration And Invasion ◽  
Steroidogenic Factor 1 ◽  
Mesenchymal Transition ◽  
Aggressive Cancer ◽  
Potential Strategy ◽  
Plasmid Transfection ◽  
Adrenocortical Carcinomas

Abstract Background: Adrenocortical carcinomas (ACC) are rare and aggressive cancer. Our previous study has revealed that the transcription factor 21, TCF21, is downregulated in ACC and regulates steroidogenic factor 1 (SF-1) binding to the SF-1 E-box promoter. In addition, it could be found that TCF21 is a predictor of Overall Survival (OS) in adult carcinomas. Methods: In this study, it was investigated the correlation between TCF21 expression and the promoter methylation status in adrenocortical tumor cells, carcinomas and adenoma. The biological function and potential molecular mechanism of TCF21 restoration in migration and invasion of ACC cells was examined. Results: We could be demonstrated a negative correlation between the level of TCF21 expression and methylation of its promoter in adenoma and carcinoma cells indicating the epigenetic control of TCF21 expression. It was also demonstrated that the expression of TCF21 inhibits migration and invasion in the ACC cell lines, H295R and SW-13 cells, using, respectively, plasmid transfection and CRISPR system to express TCF21. Furthermore, it could be investigated the TCF21 function as tumor suppressor probably through Kisspeptin 1 (KISS-1) expression and Epithelial-Mesenchymal Transition (EMT) reversion, as well as the modulation of several metalloproteinases in ACC cells. Conclusions: Our results suggest that enhancement of TCF21 expression levels may be a potential strategy to revert invasive abilities in adrenocortical carcinomas.

scholarly journals Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-βPathway

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Aling Shen ◽  
Hongwei Chen ◽  
Youqin Chen ◽  
Jiumao Lin ◽  
Wei Lin ◽  
...  
Keyword(s):  
Multidrug Resistance ◽  
Colorectal Carcinoma ◽  
Epithelial Mesenchymal Transition ◽  
Carcinoma Cells ◽  
Migration And Invasion ◽  
Dependent Manner ◽  
Mesenchymal Transition ◽  
Folk Remedy ◽  
Pien Tze Huang ◽  
Human Colorectal Carcinoma

The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multidrug resistance (MDR) and epithelial-mesenchymal transition (EMT) as well as the activation of TGF-βpathway. We found that PZH dose-dependently inhibited the viability of HCT-8/5-FU cells which were insensitive to treatment of 5-FU and ADM, demonstrating the ability of PZH to overcome chemoresistance. Furthermore, PZH increased the intercellular accumulation of Rhodamine-123 and downregulated the expression of ABCG2 in HCT-8/5-FU cells. In addition, drug resistance induced the process of EMT in HCT-8 cells as evidenced by EMT-related morphological changes and alteration in the expression of EMT-regulatory factors, which however was neutralized by PZH treatment. Moreover, PZH inhibited MDR/EMT-enhanced migration and invasion capabilities of HCT-8 cells in a dose-dependent manner and suppressed MDR-induced activation of TGF-βsignaling in HCT-8/5-FU cells. Taken together, our study suggests that PZH can effectively overcome MDR and inhibit EMT in human colorectal carcinoma cells via suppression of the TGF-βpathway.

miR-199a-5p suppresses epithelial- mesenchymal-transition in anaplastic thyroid carcinoma cells via targeting Snail signals

2020 ◽  
Vol 29 (3) ◽  
pp. 317-326
Author(s):  
Fengyun Hao ◽  
Ya-Nan Bi ◽  
Lei Wang ◽  
Yubing Wang ◽  
Jilei Ma ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Epithelial Mesenchymal Transition ◽  
Anaplastic Thyroid Carcinoma ◽  
Carcinoma Cells ◽  
Migration And Invasion ◽  
Mesenchymal Transition ◽  
Novel Approach ◽  
Accurate Expression

MicroRNAs (miRNAs) have been validated to play prominent roles in the occurrence and development of anaplastic thyroid carcinoma (ATC). miR-199a-5p was previously reported to act as a tumor suppressor or oncomiRNA in various types of cancer. However, its accurate expression, function, and mechanism in ATC remain unclear. Here, we find that miR-199a-5p is significantly downregulated in ATC tissues compared with adjacent non-cancerous tissues. Overexpression of miR-199a-5p significantly inhibits migration and invasion of ATC cells in vitro, and lung metastasis in vivo. Importantly, miR-199a-5p suppresses epithelial-mesenchymal transition (EMT) both in vitro and in vivo by targeting Snail. Taken together, this study reveals that miR-199a-5p is critical to the EMT progression in ATC cells. Targeting the pathway described here may be a novel approach for inhibiting metastasis of ATC.

Paclitaxel-Containing Nano-Apoliposomes Attenuate the Growth and Epithelial-Mesenchymal Transition of Cisplatin-Resistant Nasopharyngeal Carcinoma Cells

2021 ◽  
Vol 13 (9) ◽  
pp. 1637-1643
Author(s):  
Zhenxi Cai
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Epithelial Mesenchymal Transition ◽  
Neck Region ◽  
Clinical Treatment ◽  
Carcinoma Cells ◽  
Migration And Invasion ◽  
Mrna Levels ◽  
Mesenchymal Transition ◽  
Cell Behaviors

Nasopharyngeal carcinoma, a type of malignant tumor of the head and neck region, has strong resistance to anticancer drugs, which seriously hinders clinical treatment. In this study, we investigated the effects of different concentrations of paclitaxel-containing nano-apoliposomes on cisplatin (DDP)-resistant nasopharyngeal carcinoma cells in vitro, referred to as CNE1/DDP and CNE2/DDP. Cell behaviors were then analyzed, including proliferation, migration, and invasion abilities. In addition, levels of proteins related to apoptosis and the epithelial-mesenchymal transition (EMT) were analyzed using western blot assays and mRNA levels of EMT-related genes were measured using qRT-PCR. Our results demonstrated that paclitaxel-containing nano-apoliposomes decrease proliferation, migration, invasion, and EMT of CNE1/DDP and CNE2/DDP cells, demonstrating their inhibitory effects on cisplatin-resistant nasopharyngeal carcinoma cells. This work demonstrates the potential value of paclitaxe-containing nano-apoliposomes in the clinical treatment of drug-resistant nasopharyngeal carcinoma.

Latent Membrane Protein 1 Antibody Inhibits Cell Migration, Invasion and Epithelial-Mesenchymal Transition of Nasopharyngeal Carcinoma Stem Cell via Regulating Wnt/β-Catenin Signaling Pathway

2020 ◽  
Vol 10 (7) ◽  
pp. 930-938
Author(s):  
Dawei Zhang ◽  
Lin Xiong ◽  
Liang Li ◽  
Yuan Chen ◽  
Xiaojun Tang ◽  
...  
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Epithelial Mesenchymal Transition ◽  
Animal Experiments ◽  
Migration And Invasion ◽  
Western Blot Assay ◽  
Mesenchymal Transition ◽  
Potential Strategy ◽  
And Migration

Objective: In order to investigate the effects of LMP1-Fab antibody on Nasopharyngeal carcinoma (NPC) cancer stem cells (CSCs). Methods/ Results: Methods were performed to study the effects of LMP1-Fab antibody on NPC CSCs in vivo and in vitro, for example, transwell chamber assay, wound healing assay, western blot assay, quantitative real-time PCR assay animal experiments, animal fluorescence imaging, H&E staining, immunohistochemistry. We identified that LMP1 activated the migration and invasion of NPC. Whereas the LMP1-Fab antibody inhibited cell invasion, epithelial-mesenchymal transition (EMT) and migration of NPC CSCs in LMP1+ HNE2 cells. Furthermore, LMP1-Fab antibody significantly increased the expression of E-cadherin, and reduced the expressions of vimentin,N -cadherin and Slug in LMP1+ HNE2 CSCs cells. Mechanistically, LMP1-Fab antibody inhibited lung and liver metastasis by regulating the wnt/ -catenin pathway in the nude mice. Conclusion: These results suggested that the novel antibody-targeting LMP1 is likely to be a potential strategy for the treatment of NPC.

Sign in / Sign up

Export Citation Format

Share Document